2020 Q2 Form 10-Q Financial Statement

#000088064120000068 Filed on August 07, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $9.661M $8.750M
YoY Change 10.41% 9.46%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $380.0K $290.0K
YoY Change 31.03% 3.57%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $904.0K $1.061M
YoY Change -14.8% 85.17%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $3.413M $2.487M
YoY Change 37.23% -17.57%
Income Tax $594.0K $361.0K
% Of Pretax Income 17.4% 14.52%
Net Earnings $2.819M $2.126M
YoY Change 32.6% -15.67%
Net Earnings / Revenue 29.18% 24.3%
Basic Earnings Per Share $0.83 $0.62
Diluted Earnings Per Share $0.83 $0.62
COMMON SHARES
Basic Shares Outstanding 3.410M shares 3.425M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $38.36M $18.36M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $19.05M $19.15M
YoY Change -0.55% -1.54%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.023B $833.5M
YoY Change 22.72% 7.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $4.200M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.200M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $9.300M $9.800M
YoY Change -5.1% 18.07%
Total Long-Term Liabilities $9.300M $9.800M
YoY Change -5.1% 18.07%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.200M
Total Long-Term Liabilities $9.300M $9.800M
Total Liabilities $921.3M $740.8M
YoY Change 24.38% 7.3%
SHAREHOLDERS EQUITY
Retained Earnings $78.39M $71.60M
YoY Change 9.48% 7.97%
Common Stock $8.473M $8.519M
YoY Change -0.54% -1.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $101.6M $92.74M
YoY Change
Total Liabilities & Shareholders Equity $1.023B $833.5M
YoY Change 22.72% 7.52%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income $2.819M $2.126M
YoY Change 32.6% -15.67%
Depreciation, Depletion And Amortization $380.0K $290.0K
YoY Change 31.03% 3.57%
Cash From Operating Activities $1.890M $2.240M
YoY Change -15.63% 82.11%
INVESTING ACTIVITIES
Capital Expenditures -$130.0K -$180.0K
YoY Change -27.78% -14.29%
Acquisitions
YoY Change
Other Investing Activities -$103.6M -$17.06M
YoY Change 507.03% 12.31%
Cash From Investing Activities -$103.7M -$17.24M
YoY Change 501.39% 11.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 117.1M 21.14M
YoY Change 453.97% -615.61%
NET CHANGE
Cash From Operating Activities 1.890M 2.240M
Cash From Investing Activities -103.7M -17.24M
Cash From Financing Activities 117.1M 21.14M
Net Change In Cash 15.32M 6.140M
YoY Change 149.51% -133.61%
FREE CASH FLOW
Cash From Operating Activities $1.890M $2.240M
Capital Expenditures -$130.0K -$180.0K
Free Cash Flow $2.020M $2.420M
YoY Change -16.53% 68.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Entity Central Index Key
EntityCentralIndexKey
0000880641
dei No Trading Symbol Flag
NoTradingSymbolFlag
efsi Financing Receivable Modifications Number Of Additional Contracts
FinancingReceivableModificationsNumberOfAdditionalContracts
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.24
CY2019Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.25
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.26
CY2020Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.26
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000 shares
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3430103 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3409689 shares
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
346000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
796000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-96000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
653000 USD
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
10
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
10
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q1 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
3685 shares
CY2019Q2 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
5708 shares
CY2020Q1 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
3514 shares
CY2020Q2 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
0 shares
CY2019Q1 us-gaap Stock Issued During Period Shares Employee Benefit Plan
StockIssuedDuringPeriodSharesEmployeeBenefitPlan
0 shares
CY2019Q2 us-gaap Stock Issued During Period Shares Employee Benefit Plan
StockIssuedDuringPeriodSharesEmployeeBenefitPlan
4064 shares
CY2020Q1 us-gaap Stock Issued During Period Shares Employee Benefit Plan
StockIssuedDuringPeriodSharesEmployeeBenefitPlan
0 shares
CY2020Q2 us-gaap Stock Issued During Period Shares Employee Benefit Plan
StockIssuedDuringPeriodSharesEmployeeBenefitPlan
2761 shares
CY2019Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
10000 shares
CY2019Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
0 shares
CY2020Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
9933 shares
CY2020Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
0 shares
CY2019Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
1500 shares
CY2019Q2 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
43555 shares
CY2020Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
38614 shares
CY2020Q2 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-20146
dei Entity Registrant Name
EntityRegistrantName
EAGLE FINANCIAL SERVICES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
VA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
54-1601306
dei Entity Address Address Line1
EntityAddressAddressLine1
2 East Main Street P.O. Box 391
dei Entity Address City Or Town
EntityAddressCityOrTown
Berryville,
dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
22611
dei City Area Code
CityAreaCode
540
dei Local Phone Number
LocalPhoneNumber
955-2510
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3412636 shares
CY2020Q2 us-gaap Cash And Due From Banks
CashAndDueFromBanks
9780000 USD
CY2019Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
10920000 USD
CY2020Q2 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
28319000 USD
CY2019Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
22487000 USD
CY2020Q2 us-gaap Federal Funds Sold
FederalFundsSold
264000 USD
CY2019Q4 us-gaap Federal Funds Sold
FederalFundsSold
252000 USD
CY2020Q2 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
38363000 USD
CY2019Q4 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
33659000 USD
CY2020Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
145617000 USD
CY2019Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
165003000 USD
CY2020Q2 us-gaap Restricted Investments
RestrictedInvestments
1268000 USD
CY2019Q4 us-gaap Restricted Investments
RestrictedInvestments
1197000 USD
CY2020Q2 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
788934000 USD
CY2019Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
644760000 USD
CY2020Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
6365000 USD
CY2019Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
4973000 USD
CY2020Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
782569000 USD
CY2019Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
639787000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19047000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19297000 USD
CY2020Q2 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
442000 USD
CY2019Q4 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
183000 USD
CY2020Q2 us-gaap Other Assets
OtherAssets
35595000 USD
CY2019Q4 us-gaap Other Assets
OtherAssets
18194000 USD
CY2020Q2 us-gaap Assets
Assets
1022901000 USD
CY2019Q4 us-gaap Assets
Assets
877320000 USD
CY2020Q2 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
351547000 USD
CY2019Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
269171000 USD
CY2020Q2 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
417458000 USD
CY2019Q4 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
364175000 USD
CY2020Q2 us-gaap Time Deposits
TimeDeposits
138905000 USD
CY2019Q4 us-gaap Time Deposits
TimeDeposits
138198000 USD
CY2020Q2 us-gaap Deposits Domestic
DepositsDomestic
907910000 USD
CY2019Q4 us-gaap Deposits Domestic
DepositsDomestic
771544000 USD
CY2020Q2 us-gaap Other Liabilities
OtherLiabilities
13422000 USD
CY2019Q4 us-gaap Other Liabilities
OtherLiabilities
9450000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
921332000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
780994000 USD
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
8473000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
8529000 USD
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10771000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11406000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
78388000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
74909000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3937000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1482000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
101569000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
96326000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1022901000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
877320000 USD
CY2020Q2 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
8773000 USD
CY2019Q2 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
7690000 USD
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
16712000 USD
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
15208000 USD
CY2020Q2 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
715000 USD
CY2019Q2 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
760000 USD
us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
1610000 USD
us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
1545000 USD
CY2020Q2 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
152000 USD
CY2019Q2 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
227000 USD
us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
319000 USD
us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
469000 USD
CY2020Q2 us-gaap Dividend Income Operating
DividendIncomeOperating
15000 USD
CY2019Q2 us-gaap Dividend Income Operating
DividendIncomeOperating
17000 USD
us-gaap Dividend Income Operating
DividendIncomeOperating
34000 USD
us-gaap Dividend Income Operating
DividendIncomeOperating
33000 USD
CY2020Q2 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
6000 USD
CY2019Q2 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
55000 USD
us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
92000 USD
us-gaap Interest Expense Deposits
InterestExpenseDeposits
1999000 USD
CY2020Q2 us-gaap Interest Expense Federal Funds Purchased
InterestExpenseFederalFundsPurchased
0 USD
CY2019Q2 us-gaap Interest Expense Federal Funds Purchased
InterestExpenseFederalFundsPurchased
6000 USD
us-gaap Interest Expense Federal Funds Purchased
InterestExpenseFederalFundsPurchased
0 USD
us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
86000 USD
CY2020Q2 us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
0 USD
CY2019Q2 us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
1000 USD
us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
1000 USD
us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
2000 USD
CY2020Q2 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
9661000 USD
CY2019Q2 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
8750000 USD
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
18768000 USD
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
17343000 USD
CY2020Q2 us-gaap Interest Expense Deposits
InterestExpenseDeposits
879000 USD
CY2019Q2 us-gaap Interest Expense Deposits
InterestExpenseDeposits
1055000 USD
us-gaap Interest Expense Deposits
InterestExpenseDeposits
1981000 USD
us-gaap Interest Expense Federal Funds Purchased
InterestExpenseFederalFundsPurchased
31000 USD
CY2020Q2 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
25000 USD
CY2019Q2 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
0 USD
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
25000 USD
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
0 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
904000 USD
CY2019Q2 us-gaap Interest Expense
InterestExpense
1061000 USD
us-gaap Interest Expense
InterestExpense
2006000 USD
us-gaap Interest Expense
InterestExpense
2030000 USD
CY2020Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
8757000 USD
CY2019Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
7689000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
16762000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
15313000 USD
CY2020Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
752000 USD
CY2019Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
256000 USD
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
655000 USD
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
450000 USD
CY2020Q2 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
8005000 USD
CY2019Q2 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
7433000 USD
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
16107000 USD
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
14863000 USD
CY2020Q2 efsi Noninterest Income Fiduciary Activities
NoninterestIncomeFiduciaryActivities
403000 USD
CY2019Q2 efsi Noninterest Income Fiduciary Activities
NoninterestIncomeFiduciaryActivities
375000 USD
efsi Noninterest Income Fiduciary Activities
NoninterestIncomeFiduciaryActivities
700000 USD
efsi Noninterest Income Fiduciary Activities
NoninterestIncomeFiduciaryActivities
657000 USD
CY2020Q2 efsi Noninterest Income Service Chargeson Deposit Accounts
NoninterestIncomeServiceChargesonDepositAccounts
170000 USD
CY2019Q2 efsi Noninterest Income Service Chargeson Deposit Accounts
NoninterestIncomeServiceChargesonDepositAccounts
282000 USD
efsi Noninterest Income Service Chargeson Deposit Accounts
NoninterestIncomeServiceChargesonDepositAccounts
454000 USD
efsi Noninterest Income Service Chargeson Deposit Accounts
NoninterestIncomeServiceChargesonDepositAccounts
567000 USD
CY2020Q2 efsi Noninterest Income Other Service Chargesand Fees
NoninterestIncomeOtherServiceChargesandFees
1147000 USD
CY2019Q2 efsi Noninterest Income Other Service Chargesand Fees
NoninterestIncomeOtherServiceChargesandFees
1192000 USD
us-gaap Noninterest Income
NoninterestIncome
3722000 USD
CY2020Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
4373000 USD
CY2019Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
3874000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
8461000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
7416000 USD
efsi Noninterest Income Other Service Chargesand Fees
NoninterestIncomeOtherServiceChargesandFees
2251000 USD
efsi Noninterest Income Other Service Chargesand Fees
NoninterestIncomeOtherServiceChargesandFees
2263000 USD
CY2020Q2 efsi Gain Loss On Sale Of Bank Premises And Equipment
GainLossOnSaleOfBankPremisesAndEquipment
0 USD
CY2019Q2 efsi Gain Loss On Sale Of Bank Premises And Equipment
GainLossOnSaleOfBankPremisesAndEquipment
0 USD
efsi Gain Loss On Sale Of Bank Premises And Equipment
GainLossOnSaleOfBankPremisesAndEquipment
0 USD
efsi Gain Loss On Sale Of Bank Premises And Equipment
GainLossOnSaleOfBankPremisesAndEquipment
120000 USD
CY2020Q2 us-gaap Noninterest Income Other
NoninterestIncomeOther
173000 USD
CY2019Q2 us-gaap Noninterest Income Other
NoninterestIncomeOther
29000 USD
us-gaap Noninterest Income Other
NoninterestIncomeOther
178000 USD
us-gaap Noninterest Income Other
NoninterestIncomeOther
118000 USD
CY2020Q2 us-gaap Noninterest Income
NoninterestIncome
2422000 USD
CY2019Q2 us-gaap Noninterest Income
NoninterestIncome
1878000 USD
us-gaap Noninterest Income
NoninterestIncome
4112000 USD
CY2020Q2 us-gaap Occupancy Net
OccupancyNet
403000 USD
CY2019Q2 us-gaap Occupancy Net
OccupancyNet
401000 USD
us-gaap Occupancy Net
OccupancyNet
798000 USD
us-gaap Occupancy Net
OccupancyNet
829000 USD
CY2020Q2 us-gaap Equipment Expense
EquipmentExpense
252000 USD
CY2019Q2 us-gaap Equipment Expense
EquipmentExpense
217000 USD
us-gaap Equipment Expense
EquipmentExpense
484000 USD
us-gaap Equipment Expense
EquipmentExpense
419000 USD
CY2020Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
152000 USD
CY2019Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
249000 USD
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
357000 USD
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
467000 USD
CY2020Q2 us-gaap Supplies And Postage Expense
SuppliesAndPostageExpense
34000 USD
CY2019Q2 us-gaap Supplies And Postage Expense
SuppliesAndPostageExpense
37000 USD
us-gaap Supplies And Postage Expense
SuppliesAndPostageExpense
66000 USD
us-gaap Supplies And Postage Expense
SuppliesAndPostageExpense
66000 USD
CY2020Q2 efsi Atm Network Fees
AtmNetworkFees
243000 USD
CY2019Q2 efsi Atm Network Fees
AtmNetworkFees
331000 USD
efsi Atm Network Fees
AtmNetworkFees
485000 USD
efsi Atm Network Fees
AtmNetworkFees
561000 USD
CY2020Q2 efsi Other Real Estate Owned Expense
OtherRealEstateOwnedExpense
-3000 USD
CY2019Q2 efsi Other Real Estate Owned Expense
OtherRealEstateOwnedExpense
1000 USD
efsi Other Real Estate Owned Expense
OtherRealEstateOwnedExpense
-1000 USD
efsi Other Real Estate Owned Expense
OtherRealEstateOwnedExpense
1000 USD
CY2020Q2 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
0 USD
CY2019Q2 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-70000 USD
us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
132000 USD
us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-70000 USD
CY2020Q2 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
41000 USD
CY2019Q2 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
52000 USD
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
41000 USD
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
105000 USD
CY2020Q2 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
161000 USD
CY2019Q2 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
110000 USD
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
281000 USD
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
220000 USD
CY2020Q2 efsi Bank Franchise Tax
BankFranchiseTax
176000 USD
CY2019Q2 efsi Bank Franchise Tax
BankFranchiseTax
164000 USD
efsi Bank Franchise Tax
BankFranchiseTax
350000 USD
efsi Bank Franchise Tax
BankFranchiseTax
310000 USD
CY2020Q2 us-gaap Professional Fees
ProfessionalFees
317000 USD
CY2019Q2 us-gaap Professional Fees
ProfessionalFees
237000 USD
us-gaap Professional Fees
ProfessionalFees
671000 USD
us-gaap Professional Fees
ProfessionalFees
622000 USD
CY2020Q2 efsi Dataprocessingfees
Dataprocessingfees
382000 USD
CY2019Q2 efsi Dataprocessingfees
Dataprocessingfees
303000 USD
efsi Dataprocessingfees
Dataprocessingfees
863000 USD
efsi Dataprocessingfees
Dataprocessingfees
543000 USD
CY2020Q2 us-gaap Other Noninterest Expense
OtherNoninterestExpense
483000 USD
CY2019Q2 us-gaap Other Noninterest Expense
OtherNoninterestExpense
778000 USD
us-gaap Other Noninterest Expense
OtherNoninterestExpense
1165000 USD
us-gaap Other Noninterest Expense
OtherNoninterestExpense
1426000 USD
CY2020Q2 us-gaap Noninterest Expense
NoninterestExpense
7014000 USD
CY2019Q2 us-gaap Noninterest Expense
NoninterestExpense
6824000 USD
us-gaap Noninterest Expense
NoninterestExpense
13889000 USD
us-gaap Noninterest Expense
NoninterestExpense
13055000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3413000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2487000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
6330000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
5530000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
594000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
361000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1070000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
833000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
2819000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
2126000 USD
us-gaap Net Income Loss
NetIncomeLoss
5260000 USD
us-gaap Net Income Loss
NetIncomeLoss
4697000 USD
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.83
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.62
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.36
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.54
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.36
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
2819000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
2126000 USD
us-gaap Net Income Loss
NetIncomeLoss
5260000 USD
us-gaap Net Income Loss
NetIncomeLoss
4697000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-361000 USD
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1304000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2455000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2994000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2455000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2994000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2458000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3430000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7715000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7691000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
87599000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
2571000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
86000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
116000 USD
CY2019Q1 efsi Changes In Shareholder Equity Retirement Of Common Stock
ChangesInShareholderEquityRetirementOfCommonStock
-47000 USD
CY2019Q1 us-gaap Dividends Common Stock
DividendsCommonStock
830000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
91185000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
2126000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
116000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
179000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
138000 USD
CY2019Q2 efsi Changes In Shareholder Equity Retirement Of Common Stock
ChangesInShareholderEquityRetirementOfCommonStock
-1451000 USD
CY2019Q2 us-gaap Dividends Common Stock
DividendsCommonStock
855000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
92742000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
96326000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
2441000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
114000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
111000 USD
CY2020Q1 efsi Changes In Shareholder Equity Retirement Of Common Stock
ChangesInShareholderEquityRetirementOfCommonStock
-1116000 USD
CY2020Q1 us-gaap Dividends Common Stock
DividendsCommonStock
893000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
99799000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
2819000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
114000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
86000 USD
CY2020Q2 us-gaap Dividends Common Stock
DividendsCommonStock
888000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
101569000 USD
us-gaap Net Income Loss
NetIncomeLoss
5260000 USD
us-gaap Net Income Loss
NetIncomeLoss
4697000 USD
us-gaap Depreciation
Depreciation
516000 USD
us-gaap Depreciation
Depreciation
461000 USD
efsi Amortization Of Intangible And Other Assets
AmortizationOfIntangibleAndOtherAssets
216000 USD
efsi Amortization Of Intangible And Other Assets
AmortizationOfIntangibleAndOtherAssets
115000 USD
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
655000 USD
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
450000 USD
us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
132000 USD
us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-70000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
120000 USD
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-2000 USD
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
0 USD
us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
529000 USD
us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
-3000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
228000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
202000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-371000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-219000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2650000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
875000 USD
us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-148000 USD
us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-956000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3789000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4266000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
23895000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
8239000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
24893000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
7953000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
25636000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
9989000 USD
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
2125000 USD
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
0 USD
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
2196000 USD
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
31000 USD
us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
12000000 USD
us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
266000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
667000 USD
us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
183000 USD
us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
36000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
257000 USD
us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
13000 USD
us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
0 USD
us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
143762000 USD
us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
33255000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-132751000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27457000 USD
us-gaap Increase Decrease In Other Deposits
IncreaseDecreaseInOtherDeposits
135659000 USD
us-gaap Increase Decrease In Other Deposits
IncreaseDecreaseInOtherDeposits
22090000 USD
us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
707000 USD
us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
5730000 USD
us-gaap Increase Decrease In Federal Funds Purchased
IncreaseDecreaseInFederalFundsPurchased
0 USD
us-gaap Increase Decrease In Federal Funds Purchased
IncreaseDecreaseInFederalFundsPurchased
1871000 USD
efsi Issuance Of Common Stock Employee Benefit Plan
IssuanceOfCommonStockEmployeeBenefitPlan
86000 USD
efsi Issuance Of Common Stock Employee Benefit Plan
IssuanceOfCommonStockEmployeeBenefitPlan
138000 USD
efsi Paymentsfor Retirement Of Common Stock
PaymentsforRetirementOfCommonStock
1116000 USD
efsi Paymentsfor Retirement Of Common Stock
PaymentsforRetirementOfCommonStock
1498000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1670000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1390000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
133666000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23199000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4704000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33659000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18353000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38363000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18361000 USD
us-gaap Interest Paid Net
InterestPaidNet
2048000 USD
us-gaap Interest Paid Net
InterestPaidNet
2008000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
168000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
3108000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
3790000 USD
us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
325000 USD
us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
15000 USD
us-gaap Stock Issued1
StockIssued1
111000 USD
us-gaap Stock Issued1
StockIssued1
295000 USD
us-gaap Increase Decrease In Deferred Leasing Fees
IncreaseDecreaseInDeferredLeasingFees
549000 USD
us-gaap Increase Decrease In Deferred Leasing Fees
IncreaseDecreaseInDeferredLeasingFees
3751000 USD
CY2020Q2 efsi Consolidated Financial Ownership Wholly Owned Subsidiary Percentage
ConsolidatedFinancialOwnershipWhollyOwnedSubsidiaryPercentage
1
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
500000 shares
efsi Deferred Compensation Arrangements Unrecognized Compensation Cost Related To Unvested Restricted Stock
DeferredCompensationArrangementsUnrecognizedCompensationCostRelatedToUnvestedRestrictedStock
200000 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
18488 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
30.39
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
16701 shares
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
29.72
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
11925 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
31.05
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
17200 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
30.84
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
9933 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
30.13
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
10000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
29.38
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
20480 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
30.90
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
23901 shares
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
30.67
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3409689 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3425305 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3423387 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3441668 shares
CY2020Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
140687000 USD
CY2020Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
4935000 USD
CY2020Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
5000 USD
CY2020Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
145617000 USD
CY2019Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
163181000 USD
CY2019Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2187000 USD
CY2019Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
365000 USD
CY2019Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
165003000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
24900000 USD
us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
529000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
8000000.0 USD
us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
21000 USD
us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
24000 USD
CY2020Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
743000 USD
CY2020Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
5000 USD
CY2020Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
0 USD
CY2020Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 USD
CY2020Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
743000 USD
CY2020Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
5000 USD
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
28102000 USD
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
316000 USD
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
8191000 USD
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
49000 USD
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
36293000 USD
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
365000 USD
CY2020Q2 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1
1
CY2020Q2 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1
1
CY2019Q4 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1
28
CY2019Q4 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1
28
CY2020Q2 us-gaap Pledged Financial Instruments Not Separately Reported Securities Pledged
PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesPledged
3000000.0 USD
CY2020Q2 us-gaap Restricted Investments
RestrictedInvestments
1268000 USD
CY2019Q4 us-gaap Restricted Investments
RestrictedInvestments
1197000 USD
CY2020Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
789120000 USD
CY2019Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
645207000 USD
CY2020Q2 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
186000 USD
CY2019Q4 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
447000 USD
CY2020Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
6365000 USD
CY2019Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
4973000 USD
CY2020Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
782569000 USD
CY2019Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
639787000 USD
CY2019 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
201000 USD
CY2019Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0 USD
CY2019Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
2185000 USD
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4973000 USD
CY2018Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5456000 USD
CY2018Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5456000 USD
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
655000 USD
CY2019 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
629000 USD
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
450000 USD
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
880000 USD
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
99000 USD
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
143000 USD
CY2019 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
1313000 USD
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
970000 USD
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
6365000 USD
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4973000 USD
CY2019Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5035000 USD
CY2020Q2 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
3396000 USD
CY2020Q2 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
785724000 USD
CY2020Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
789120000 USD
CY2020Q2 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
665000 USD
CY2020Q2 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
4238000 USD
CY2019Q4 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
3789000 USD
CY2019Q4 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
641418000 USD
CY2019Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
645207000 USD
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4973000 USD
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
143000 USD
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
880000 USD
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
655000 USD
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
6365000 USD
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
260000 USD
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
6105000 USD
CY2020Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
789120000 USD
CY2020Q2 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
7145000 USD
CY2020Q2 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
781975000 USD
CY2018Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5456000 USD
CY2019 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
1313000 USD
CY2019 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
201000 USD
CY2019 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
629000 USD
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4973000 USD
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
300000 USD
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
4673000 USD
CY2019Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
645207000 USD
CY2019Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
7403000 USD
CY2019Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
637804000 USD
CY2020Q2 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
8223000 USD
CY2020Q2 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
7213000 USD
CY2020Q2 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
260000 USD
us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
7386000 USD
us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
113000 USD
CY2019Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
8381000 USD
CY2019Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
7420000 USD
CY2019Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
300000 USD
CY2019 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
7685000 USD
CY2019 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
301000 USD
CY2020Q2 us-gaap Notes Receivable Gross
NotesReceivableGross
772650000 USD
CY2019Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
635666000 USD
us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
14
us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
14
CY2020Q2 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
2700000 USD
CY2019 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
18
CY2019 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
18
CY2019Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
3000000 USD
CY2020Q2 efsi Financing Receivable Modifications Nonaccrual Numberof Contracts
FinancingReceivableModificationsNonaccrualNumberofContracts
3
CY2020Q2 efsi Financing Receivable Modifications Nonaccrual Recorded Investment
FinancingReceivableModificationsNonaccrualRecordedInvestment
145000 USD
CY2019Q4 efsi Financing Receivable Modifications Nonaccrual Numberof Contracts
FinancingReceivableModificationsNonaccrualNumberofContracts
4
CY2019Q4 efsi Financing Receivable Modifications Nonaccrual Recorded Investment
FinancingReceivableModificationsNonaccrualRecordedInvestment
401000 USD
efsi Financing Receivable Modifications Number Of Additional Contracts
FinancingReceivableModificationsNumberOfAdditionalContracts
0
us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
1
efsi Period Past Due Loan Considered Payment Default
PeriodPastDueLoanConsideredPaymentDefault
P30D
CY2020Q2 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
351547000 USD
CY2019Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
269171000 USD
CY2020Q2 us-gaap Interest Bearing Domestic Deposit Negotiable Order Of Withdrawal Now
InterestBearingDomesticDepositNegotiableOrderOfWithdrawalNOW
110032000 USD
CY2019Q4 us-gaap Interest Bearing Domestic Deposit Negotiable Order Of Withdrawal Now
InterestBearingDomesticDepositNegotiableOrderOfWithdrawalNOW
102337000 USD
CY2020Q2 us-gaap Interest Bearing Domestic Deposit Money Market
InterestBearingDomesticDepositMoneyMarket
183492000 USD
CY2019Q4 us-gaap Interest Bearing Domestic Deposit Money Market
InterestBearingDomesticDepositMoneyMarket
154133000 USD
CY2020Q2 us-gaap Interest Bearing Domestic Deposit Savings
InterestBearingDomesticDepositSavings
123934000 USD
CY2019Q4 us-gaap Interest Bearing Domestic Deposit Savings
InterestBearingDomesticDepositSavings
107705000 USD
CY2020Q2 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
417458000 USD
CY2019Q4 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
364175000 USD
CY2020Q2 efsi Time Deposits Lessthan250000
TimeDepositsLessthan250000
60033000 USD
CY2019Q4 efsi Time Deposits Lessthan250000
TimeDepositsLessthan250000
59094000 USD
CY2020Q2 efsi Time Deposits250000or More
TimeDeposits250000orMore
78872000 USD
CY2019Q4 efsi Time Deposits250000or More
TimeDeposits250000orMore
79104000 USD
CY2020Q2 us-gaap Time Deposits
TimeDeposits
138905000 USD
CY2019Q4 us-gaap Time Deposits
TimeDeposits
138198000 USD
CY2020Q2 us-gaap Deposits Domestic
DepositsDomestic
907910000 USD
CY2019Q4 us-gaap Deposits Domestic
DepositsDomestic
771544000 USD
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
4160000 USD
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3680000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4079000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3618000 USD
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P18Y
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P20Y
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0335
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0362
us-gaap Operating Lease Cost
OperatingLeaseCost
156000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
131000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
8000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
7000 USD
us-gaap Lease Cost
LeaseCost
164000 USD
us-gaap Lease Cost
LeaseCost
138000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
138000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
100000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
110000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
319000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
321000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
324000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
327000 USD
CY2020Q2 efsi Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
346000 USD
CY2020Q2 efsi Lessee Operating Lease Liability Payments Due After Year Six
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix
4039000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5786000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1626000 USD
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
4160000 USD
CY2020Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
145617000 USD
CY2019Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
165003000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4298000 USD
CY2019Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
137000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Before Reclassifications Before Tax
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
72000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Before Reclassifications Before Tax
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
1650000 USD
CY2020Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
529000 USD
CY2019Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
0 USD
CY2020Q2 efsi Other Comprehensive Income Loss Tax Effect Of Current Period Changes
OtherComprehensiveIncomeLossTaxEffectOfCurrentPeriodChanges
-96000 USD
CY2019Q2 efsi Other Comprehensive Income Loss Tax Effect Of Current Period Changes
OtherComprehensiveIncomeLossTaxEffectOfCurrentPeriodChanges
346000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-361000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1304000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3937000 USD
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1441000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1482000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1553000 USD
us-gaap Other Comprehensive Income Loss Before Reclassifications Before Tax
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
3637000 USD
us-gaap Other Comprehensive Income Loss Before Reclassifications Before Tax
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
3787000 USD
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
529000 USD
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
-3000 USD
efsi Other Comprehensive Income Loss Tax Effect Of Current Period Changes
OtherComprehensiveIncomeLossTaxEffectOfCurrentPeriodChanges
653000 USD
efsi Other Comprehensive Income Loss Tax Effect Of Current Period Changes
OtherComprehensiveIncomeLossTaxEffectOfCurrentPeriodChanges
796000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2455000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2994000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3937000 USD
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1441000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
111000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
0 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
111000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
-1000 USD
CY2019Q4 us-gaap Other Real Estate
OtherRealEstate
183000 USD
CY2018Q4 us-gaap Other Real Estate
OtherRealEstate
106000 USD
CY2018Q4 us-gaap Other Real Estate
OtherRealEstate
106000 USD
us-gaap Other Real Estate Additions
OtherRealEstateAdditions
310000 USD
CY2019 us-gaap Other Real Estate Additions
OtherRealEstateAdditions
1151000 USD
us-gaap Other Real Estate Additions
OtherRealEstateAdditions
0 USD
efsi Other Real Estate Gain On Foreclosure
OtherRealEstateGainOnForeclosure
132000 USD
CY2019 efsi Other Real Estate Gain On Foreclosure
OtherRealEstateGainOnForeclosure
192000 USD
efsi Other Real Estate Gain On Foreclosure
OtherRealEstateGainOnForeclosure
0 USD
us-gaap Other Real Estate Disposals
OtherRealEstateDisposals
183000 USD
CY2019 us-gaap Other Real Estate Disposals
OtherRealEstateDisposals
1266000 USD
us-gaap Other Real Estate Disposals
OtherRealEstateDisposals
106000 USD
us-gaap Other Real Estate Valuation Adjustments
OtherRealEstateValuationAdjustments
0 USD
CY2019 us-gaap Other Real Estate Valuation Adjustments
OtherRealEstateValuationAdjustments
0 USD
us-gaap Other Real Estate Valuation Adjustments
OtherRealEstateValuationAdjustments
0 USD
CY2020Q2 us-gaap Other Real Estate
OtherRealEstate
442000 USD
CY2019Q4 us-gaap Other Real Estate
OtherRealEstate
183000 USD
CY2019Q2 us-gaap Other Real Estate
OtherRealEstate
0 USD
CY2020Q2 efsi Other Real Estate Gross
OtherRealEstateGross
442000 USD
CY2019Q4 efsi Other Real Estate Gross
OtherRealEstateGross
183000 USD
CY2020Q2 us-gaap Real Estate Owned Valuation Allowance
RealEstateOwnedValuationAllowance
0 USD
CY2019Q4 us-gaap Real Estate Owned Valuation Allowance
RealEstateOwnedValuationAllowance
0 USD
CY2020Q2 us-gaap Other Real Estate
OtherRealEstate
442000 USD
CY2019Q4 us-gaap Other Real Estate
OtherRealEstate
183000 USD
CY2020Q2 efsi Mortgage Loans In Process Of Foreclosure Number
MortgageLoansInProcessOfForeclosureNumber
0
CY2019Q4 efsi Mortgage Loans In Process Of Foreclosure Number
MortgageLoansInProcessOfForeclosureNumber
2
CY2019Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
334000 USD
CY2020Q2 us-gaap Amortization Method Qualified Affordable Housing Project Investments
AmortizationMethodQualifiedAffordableHousingProjectInvestments
2900000 USD
CY2019Q4 us-gaap Amortization Method Qualified Affordable Housing Project Investments
AmortizationMethodQualifiedAffordableHousingProjectInvestments
3000000.0 USD
CY2020Q2 us-gaap Qualified Affordable Housing Project Investments Commitment
QualifiedAffordableHousingProjectInvestmentsCommitment
766000 USD
CY2019Q4 us-gaap Qualified Affordable Housing Project Investments Commitment
QualifiedAffordableHousingProjectInvestmentsCommitment
798000 USD
CY2020Q2 us-gaap Amortization Method Qualified Affordable Housing Project Investments Amortization
AmortizationMethodQualifiedAffordableHousingProjectInvestmentsAmortization
57000 USD
CY2019Q2 us-gaap Amortization Method Qualified Affordable Housing Project Investments Amortization
AmortizationMethodQualifiedAffordableHousingProjectInvestmentsAmortization
58000 USD
us-gaap Amortization Method Qualified Affordable Housing Project Investments Amortization
AmortizationMethodQualifiedAffordableHousingProjectInvestmentsAmortization
114000 USD
us-gaap Amortization Method Qualified Affordable Housing Project Investments Amortization
AmortizationMethodQualifiedAffordableHousingProjectInvestmentsAmortization
115000 USD
efsi Affordable Housing Tax Creditsand Other Tax Benefits Expectedto Be Received
AffordableHousingTaxCreditsandOtherTaxBenefitsExpectedtoBeReceived
316000 USD
us-gaap Affordable Housing Tax Credits And Other Tax Benefits Amount
AffordableHousingTaxCreditsAndOtherTaxBenefitsAmount
173000 USD
us-gaap Affordable Housing Tax Credits And Other Tax Benefits Amount
AffordableHousingTaxCreditsAndOtherTaxBenefitsAmount
191000 USD
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTE 13. Recent Accounting Pronouncements and Other Authoritative Guidance</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In June 2016, the Financial Accounting Standards Board ("FASB") issued ASU No. 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” The amendments in this ASU, among other things, require the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other organizations will now use forward-looking information to better inform their credit loss estimates. Many of the loss estimation techniques applied today will still be permitted, although the inputs to those techniques will change to reflect the full amount of expected credit losses. In addition, the ASU amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. At the FASB’s October 16, 2019 meeting, the Board affirmed its decision to amend the effective date of this ASU for many companies.   Public business entities that are SEC filers, excluding those meeting the smaller reporting company definition, will retain the initial required implementation date of fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019.  All other entities, including the Company, will be required to apply the guidance for fiscal years, and interim periods within those years, beginning after December 15, 2022. The Company is currently assessing the impact that ASU 2016-13 will have on its consolidated financial statements.</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> </span><span style="font-family:inherit;font-size:10pt;">The Company formed a CECL committee during 2016 which continues to meet weekly to address the compliance requirements. Historic loan data has been gathered and reviewed for completeness and accuracy. In addition, the committee has selected a third-party that is assisting in calculating the financial impact of ASU 2016-13 and anticipates running parallel allowance models under the current and new standard in advance of the required implementation date.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Effective November 25, 2019, the SEC adopted Staff Accounting Bulletin (SAB) 119. SAB 119 updated portions of SEC interpretative guidance to align with FASB ASC 326, “Financial Instruments - Credit Losses.” It covers topics including (1) measuring current expected credit losses; (2) development, governance, and documentation of a systematic methodology; (3) documenting the results of a systematic methodology; and (4) validating a systematic methodology.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740) - Simplifying the Accounting for Income Taxes.” The ASU is expected to reduce cost and complexity related to the accounting for income taxes by removing specific exceptions to general principles in Topic 740 (eliminating the need for an organization to analyze whether certain exceptions apply in a given period) and improving financial statement preparers’ application of certain income tax-related guidance. This ASU is part of the FASB’s simplification initiative to make narrow-scope simplifications and improvements to accounting standards through a series of short-term projects. For public business entities, the amendments are effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently assessing the impact that ASU 2019-12 will have on its consolidated financial statements.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In January 2020, the FASB issued ASU 2020-01, “Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.” The ASU is based on a consensus of the Emerging Issues Task Force and is expected to increase comparability in accounting for these transactions. ASU 2016-01 made targeted improvements to accounting for financial instruments, including providing an entity the ability to measure certain equity securities without a readily determinable fair value at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Among other topics, the amendments clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting. For public business entities, the amendments in the ASU are effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. Early adoption is permitted. The Company does not expect the adoption of ASU 2020-01 to have a material impact on its consolidated financial statements.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In March 2020, the FASB issued Accounting Standards Update (ASU) No. 2020-04 “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” These amendments provide temporary optional guidance to ease the potential burden in accounting for reference rate reform. The ASU provides optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued. It is intended to help stakeholders during the global market-wide reference rate transition period. The guidance is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is working to identify loans that are directly or indirectly influenced by LIBOR. The Company is assessing ASU 2020-04 and its impact on the Company’s transition away from LIBOR for its loans.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On March 12, 2020, the SEC finalized amendments to its “accelerated filer” and “large accelerated filer” definitions. The amendments increase the threshold criteria for meeting these filer classifications and were effective on April 27, 2020. Any changes in filer status are to be applied beginning with the filer’s first annual report filed with the SEC subsequent to the effective date.</span><span style="font-family:inherit;font-size:10pt;background-color:#00ffff;font-style:italic;"> </span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> </span><span style="font-family:inherit;font-size:10pt;">Prior to these changes, the Company was required to comply with section 404(b) of the Sarbanes Oxley Act concerning auditor attestation over internal control over financial reporting as an “accelerated filer” as it had more than $75 million in public float but less than $700 million at the end of the Company’s most recent second quarter.  The rule change revises the definition of “accelerated filers” to exclude entities with public float of less than $700 million and less than $100 million in annual revenues.  The Company expects that it will no longer be considered an accelerated filer under this new definition.  If the Company’s annual revenues exceed $100 million, its category will change back to “accelerated filer”.  The classifications of “accelerated filer” and “large accelerated filer” require a public company to obtain an auditor attestation concerning the effectiveness of internal control over financial reporting ("ICFR") and include the auditor's opinion on ICFR in its annual report on Form 10-K.  Non-accelerated filers also have additional time to file quarterly and annual financial statements.  All public companies are required to obtain and file annual financial statement audits, as well as provide management’s assertion on effectiveness of internal control over financial reporting, but the external auditor attestation of ICFR is not required for non-accelerated filers.  </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In March 2020, various regulatory agencies, including the Board of Governors of the Federal Reserve System and the Federal Deposit Insurance Corporation, (“the agencies”) issued an interagency statement on loan modifications and reporting for financial institutions working with customers affected by the Coronavirus. The interagency statement was effective immediately and impacted accounting for loan modifications. Under Accounting Standards Codification 310-40, “Receivables - Troubled Debt Restructurings by Creditors,” (“ASC 310-40”), a restructuring of debt constitutes a TDR if the creditor, for economic or legal reasons related to the debtor’s financial difficulties, grants a concession to the debtor that it would not otherwise consider. The agencies confirmed with the staff of the FASB that short-term modifications made on a good faith basis in response to COVID-19 to borrowers who were current prior to any relief, are not to be considered TDRs. This includes short-term (e.g., six months) modifications such as payment deferrals, fee waivers, extensions of repayment terms, or other delays in payment that are insignificant. Borrowers considered current are those that are less than 30 days past due on their contractual payments at the time a modification program is implemented. This interagency guidance is expected to have an impact on the Company’s financial statements; however, this impact cannot be quantified at this time.</span></div>

Files In Submission

Name View Source Status
0000880641-20-000068-index-headers.html Edgar Link pending
0000880641-20-000068-index.html Edgar Link pending
0000880641-20-000068.txt Edgar Link pending
0000880641-20-000068-xbrl.zip Edgar Link pending
efsi-20200630.xsd Edgar Link pending
efsi-20200630exhibit311.htm Edgar Link pending
efsi-20200630exhibit312.htm Edgar Link pending
efsi-20200630exhibit321.htm Edgar Link pending
efsi-20200630x10q.htm Edgar Link pending
efsi-20200630x10q_htm.xml Edgar Link completed
efsi-20200630_cal.xml Edgar Link unprocessable
efsi-20200630_def.xml Edgar Link unprocessable
efsi-20200630_lab.xml Edgar Link unprocessable
efsi-20200630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending